Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.160
+0.060 (5.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $41.97 million as of December 20, 2024. Its market cap has decreased by -0.65% in one year.
Market Cap
41.97M
Enterprise Value
40.17M
1-Year Change
-0.65%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $41.97M, an increase of 2,260.93%. That is a compound annual growth rate of 328.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 41.97M | 7.41% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 42.18M |
| DIH Holding US | 42.14M |
| Cardio Diagnostics Holdings | 42.08M |
| Gain Therapeutics | 41.64M |
| ImmuCell | 40.82M |
| Neuronetics | 40.73M |
| Rallybio | 40.50M |
| CASI Pharmaceuticals | 40.48M |